title: Delayed consent: will there be a shift in approach for US primary percutaneous coronary intervention trials?
authors.affiliation: MedStar Health Research Institute, Hyattsville, MD, USA.
authors.forename: Charles R
authors.initials: CR
authors.lastname: MacKay
authors.affiliation: MedStar Washington Hospital Center, Washington, DC, USA.
authors.forename: Rebecca
authors.initials: R
authors.lastname: Torguson
authors.affiliation: MedStar Washington Hospital Center, Washington, DC, USA. Electronic address: Ron.waksman@medstar.net.
authors.forename: Ron
authors.initials: R
authors.lastname: Waksman
mesh_terms: D030881:Disclosure / Q000941:ethics; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006801:Humans; D007258:Informed Consent / Q000941:ethics*; D009203:Myocardial Infarction / Q000628:therapy*; D018579:Patient Selection / Q000941:ethics*; D062645:Percutaneous Coronary Intervention / Q000379:methods*; D016032:Randomized Controlled Trials as Topic / Q000941:ethics / Q000379:methods
chemical_list: D005343:Fibrinolytic Agents